Shwe Win, MD
Hospitalist · Utica, NYNPI 1699971119
Payments from drug & device makers
Across 78 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$440
- Otsuka America Pharmaceutical, Inc.$140
- Boehringer Ingelheim$134
- Johnson & Johnson$133
- E.r. Squibb & Sons, L.L.C.$101
- CSL Behring$95
- plus $370 from 10 others
What the payments were for
- Food & beverage$1,415100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 24 | $440 |
| Otsuka America Pharmaceutical, Inc. | 10 | $140 |
| Boehringer Ingelheim | 7 | $134 |
| Johnson & Johnson | 8 | $133 |
| E.r. Squibb & Sons, L.L.C. | 6 | $101 |
| CSL Behring | 4 | $95 |
| AbbVie | 5 | $82 |
| Baxter Healthcare | 3 | $59 |
| Novartis | 2 | $51 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $48 |
| Merck | 2 | $35 |
| Edwards Lifesciences | 1 | $26 |
| Gilead | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $19 |
| Novo Nordisk | 1 | $15 |
| Abiomed | 1 | $14 |
How this compares
$1,415 in reported general payments places this provider in the 90th percentile of 1,860 hospitalist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefpodoxime Proxetil | 37 | $1,211 |
| Pantoprazole Sodium | 42 | $349 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $150 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $129 |
| Metoprolol Succinate | 18 | $98 |
| Famotidine | 13 | $92 |
| Nystatin | 12 | $90 |
| Prednisone | 26 | $85 |
| Memantine Hcl | 12 | $78 |
| Spironolactone | 18 | $63 |
| Atorvastatin Calcium | 22 | $60 |
| Losartan Potassium | 19 | $56 |
| Furosemide | 18 | $43 |
| Metoprolol Tartrate | 16 | $43 |
| Carvedilol | 12 | $33 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Utica
- Mark GoldinNew Hyde Park$666K
- Nelson Chan-HungRochester$445K
- Zainab Mogul-AshrafMiddletown$393K
- Manika SuryadevaraSyracuse$322K
- Saquib RahimFlushing$239K
- Saadia SheraziRochester$102K
- Salman AzimRochester$88K
- Farrukh AbbasRochester$84K
- Usman SiddiquiNyack$70K
- Amit NarayanNew York$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.